Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 9.33
(0.0%)
CNY 9.33
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -14.11 Million CNY | 47.57% |
| 2022 | -44.11 Million CNY | -557.0% |
| 2021 | -14.07 Million CNY | -118.3% |
| 2020 | -32.75 Million CNY | -22.06% |
| 2019 | 73.34 Million CNY | -52.22% |
| 2018 | 21.61 Million CNY | -19.23% |
| 2017 | 28.91 Million CNY | 38.57% |
| 2016 | 21.63 Million CNY | 503.12% |
| 2015 | -5.74 Million CNY | -129.8% |
| 2014 | 17.35 Million CNY | -2.51% |
| 2013 | 13.36 Million CNY | 179.92% |
| 2012 | -68.96 Million CNY | -146.18% |
| 2011 | 48.45 Million CNY | 229.39% |
| 2010 | 5.82 Million CNY | 149.82% |
| 2009 | -57.66 Million CNY | -235.33% |
| 2008 | 18.44 Million CNY | 217.05% |
| 2007 | 10.37 Million CNY | -57.82% |
| 2006 | 16.23 Million CNY | -23.69% |
| 2005 | 23.63 Million CNY | -3.32% |
| 2004 | 24.44 Million CNY | 460.65% |
| 2003 | 4.36 Million CNY | -78.56% |
| 2002 | 20.34 Million CNY | -0.99% |
| 2001 | 20.11 Million CNY | 14.26% |
| 2000 | 17.98 Million CNY | 4.21% |
| 1999 | 17.09 Million CNY | 18.61% |
| 1998 | 13.26 Million CNY | 130.13% |
| 1997 | 6.32 Million CNY | 67.26% |
| 1996 | 3.77 Million CNY | 19.08% |
| 1995 | 3.17 Million CNY | -94.41% |
| 1994 | 56.82 Million CNY | 618.53% |
| 1993 | 7.9 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -8.68 Million CNY | -35.75% |
| 2024 Q3 | 18.82 Million CNY | 317.95% |
| 2024 Q2 | -8.75 Million CNY | -1.41% |
| 2023 Q2 | -6.96 Million CNY | 16.05% |
| 2023 Q1 | -8.3 Million CNY | -127.58% |
| 2023 FY | - CNY | 47.57% |
| 2023 Q3 | -5.31 Million CNY | 23.7% |
| 2023 Q4 | -508.58 Thousand CNY | 90.44% |
| 2022 Q3 | -8.55 Million CNY | 44.98% |
| 2022 Q1 | -5.4 Million CNY | -99.89% |
| 2022 FY | - CNY | -557.0% |
| 2022 Q4 | -3.64 Million CNY | 57.38% |
| 2022 Q2 | -15.55 Million CNY | -188.01% |
| 2021 FY | - CNY | -118.3% |
| 2021 Q1 | -1.52 Million CNY | 37.05% |
| 2021 Q2 | -2.2 Million CNY | -44.92% |
| 2021 Q3 | -7.62 Million CNY | -245.9% |
| 2021 Q4 | -2.7 Million CNY | 64.54% |
| 2020 FY | - CNY | -22.06% |
| 2020 Q1 | 1.4 Million CNY | 127.47% |
| 2020 Q2 | -1.78 Million CNY | -226.95% |
| 2020 Q3 | 1.93 Million CNY | 208.28% |
| 2020 Q4 | -2.41 Million CNY | -225.0% |
| 2019 Q3 | 1.96 Million CNY | -71.29% |
| 2019 Q1 | 1.01 Million CNY | 111.37% |
| 2019 Q2 | 6.85 Million CNY | 577.92% |
| 2019 Q4 | -5.11 Million CNY | -359.97% |
| 2019 FY | - CNY | -52.22% |
| 2018 Q1 | 510.64 Thousand CNY | -97.99% |
| 2018 Q2 | 17.18 Million CNY | 3265.0% |
| 2018 Q3 | 2.42 Million CNY | -85.87% |
| 2018 Q4 | -8.89 Million CNY | -466.38% |
| 2018 FY | - CNY | -19.23% |
| 2017 Q4 | 25.45 Million CNY | 3693.6% |
| 2017 Q2 | -502.69 Thousand CNY | 73.46% |
| 2017 Q1 | -1.89 Million CNY | -108.4% |
| 2017 FY | - CNY | 38.57% |
| 2017 Q3 | -708.29 Thousand CNY | -40.9% |
| 2016 FY | - CNY | 503.12% |
| 2016 Q3 | -2.26 Million CNY | -3329.66% |
| 2016 Q2 | 70.14 Thousand CNY | 101.63% |
| 2016 Q1 | -4.31 Million CNY | 21.2% |
| 2016 Q4 | 22.53 Million CNY | 1094.68% |
| 2015 Q1 | -1.8 Million CNY | -124.28% |
| 2015 FY | - CNY | -129.8% |
| 2015 Q4 | -5.47 Million CNY | -13.07% |
| 2015 Q3 | -4.84 Million CNY | -2979.65% |
| 2015 Q2 | -157.22 Thousand CNY | 91.3% |
| 2014 Q4 | 7.44 Million CNY | 39.19% |
| 2014 FY | - CNY | -2.51% |
| 2014 Q1 | -2.03 Million CNY | -116.24% |
| 2014 Q2 | 4.12 Million CNY | 302.85% |
| 2014 Q3 | 5.35 Million CNY | 29.6% |
| 2013 FY | - CNY | 179.92% |
| 2013 Q2 | 4.89 Million CNY | 4673.4% |
| 2013 Q4 | 12.53 Million CNY | 1528.37% |
| 2013 Q3 | -877.29 Thousand CNY | -117.91% |
| 2013 Q1 | 102.64 Thousand CNY | 100.55% |
| 2012 FY | - CNY | -146.18% |
| 2012 Q4 | -18.5 Million CNY | -219.13% |
| 2012 Q2 | -13.33 Million CNY | -298.48% |
| 2012 Q3 | -5.79 Million CNY | 56.51% |
| 2012 Q1 | -3.34 Million CNY | -110.22% |
| 2011 Q4 | 32.74 Million CNY | 664.12% |
| 2011 Q1 | 4.26 Million CNY | 410.91% |
| 2011 Q3 | 4.28 Million CNY | 51.25% |
| 2011 Q2 | 2.83 Million CNY | -33.64% |
| 2011 FY | - CNY | 229.39% |
| 2010 Q1 | 1.16 Million CNY | 147.7% |
| 2010 Q2 | 3.25 Million CNY | 179.64% |
| 2010 Q3 | 1.16 Million CNY | -64.25% |
| 2010 Q4 | 835.63 Thousand CNY | -28.18% |
| 2010 FY | - CNY | 149.82% |
| 2009 Q2 | -28.86 Million CNY | -1186.44% |
| 2009 Q3 | -10.7 Million CNY | 62.91% |
| 2009 Q1 | 2.65 Million CNY | 193.87% |
| 2009 FY | - CNY | -235.33% |
| 2009 Q4 | -2.44 Million CNY | 77.21% |
| 2008 Q1 | 7.42 Million CNY | -29.13% |
| 2008 Q4 | -2.83 Million CNY | -327.12% |
| 2008 Q3 | 1.24 Million CNY | -83.28% |
| 2008 FY | - CNY | 217.05% |
| 2008 Q2 | 7.45 Million CNY | 0.37% |
| 2007 Q2 | 1.47 Million CNY | -59.32% |
| 2007 Q4 | 10.47 Million CNY | 175.91% |
| 2007 Q3 | -13.8 Million CNY | -1033.17% |
| 2007 Q1 | 3.63 Million CNY | 50.49% |
| 2007 FY | - CNY | -57.82% |
| 2006 Q1 | 6.04 Million CNY | -18.35% |
| 2006 FY | - CNY | -23.69% |
| 2006 Q4 | 2.41 Million CNY | -56.11% |
| 2006 Q3 | 5.5 Million CNY | -9.79% |
| 2006 Q2 | 6.1 Million CNY | 0.91% |
| 2005 Q3 | 4.9 Million CNY | -28.4% |
| 2005 Q1 | 6.5 Million CNY | -39.22% |
| 2005 FY | - CNY | -3.32% |
| 2005 Q2 | 6.84 Million CNY | 5.32% |
| 2005 Q4 | 7.4 Million CNY | 51.1% |
| 2004 FY | - CNY | 460.65% |
| 2004 Q4 | 10.69 Million CNY | 155.7% |
| 2004 Q1 | 4.7 Million CNY | 155.06% |
| 2004 Q2 | 6.11 Million CNY | 30.06% |
| 2004 Q3 | 4.18 Million CNY | -31.63% |
| 2003 Q2 | 8.28 Million CNY | 103.74% |
| 2003 FY | - CNY | -78.56% |
| 2003 Q4 | -8.54 Million CNY | -789.63% |
| 2003 Q1 | 4.06 Million CNY | -24.86% |
| 2003 Q3 | 1.23 Million CNY | -85.04% |
| 2002 Q3 | -1.74 Million CNY | -139.11% |
| 2002 Q4 | 5.4 Million CNY | 410.72% |
| 2002 Q1 | 2.93 Million CNY | -63.73% |
| 2002 FY | - CNY | -0.99% |
| 2002 Q2 | 4.45 Million CNY | 51.63% |
| 2001 FY | - CNY | 14.26% |
| 2001 Q4 | 8.09 Million CNY | 621.26% |
| 2001 Q3 | -1.55 Million CNY | 0.0% |
| 2000 FY | - CNY | 4.21% |
| 1999 FY | - CNY | 18.61% |
| 1998 FY | - CNY | 130.13% |
| 1997 FY | - CNY | 67.26% |
| 1996 FY | - CNY | 19.08% |
| 1995 FY | - CNY | -94.41% |
| 1994 FY | - CNY | 618.53% |
| 1993 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 5.54 Billion CNY | 100.255% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.57 Billion CNY | 100.395% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.12 Billion CNY | 101.251% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 192.74 Million CNY | 107.321% |
| Aurora Optoelectronics Co.,Ltd. | -509.76 Million CNY | 97.232% |
| NanJing Pharmaceutical Company Limited | 1.61 Billion CNY | 100.871% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 157.93 Million CNY | 108.935% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.55 Billion CNY | 100.906% |